Skip to main content
    A

    Avalo Therapeutics Inc (AVTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.13
    -0.24 (-3.26%)

    Market Cap: $448.71M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Avalo Therapeutics Inc (AVTX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Avalo Therapeutics (AVTX) has a latest price of $7.13 on Nov 17, 2026, 70.6% below its 52-week high of $24.27. Its price fell 52.8% over the past 12 months. The month-end price fell 99.9% over the 10 years through Oct 2026, a compound annual decline of 51.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $20,465.33 in Feb 2019 and its lowest $4.00 in May 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart AVTX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for AVTX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 65.6%, and over 6 months it fell 56.2%. The month-end price fell 72.5% over the 3 years through Oct 2026, a compound annual decline of 35.0%.

    PeriodChange
    1 month-38.5%
    3 months-65.6%
    6 months-56.2%
    12 months-52.8%
    12 months, with dividends-52.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-72.5%-35.0%
    5 years-99.9%-74.5%
    10 years-99.9%-51.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 263.5%, and its weakest was 2023, when it fell 99.2%.

    YearCloseChange
    2026 through Oct 2026$7.17-60.5%
    2025$18.16+144.4%
    2024$7.43-18.4%
    2023$9.10-99.2%
    2022$1,200.02-75.3%
    2021$4,859.09-35.6%
    2020$7,545.88-51.0%
    2019$15,406.16+66.9%
    2018$9,232.26+0.9%
    2017$9,146.52+263.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 39.8% below its 50-day average of $11.84 and 54.1% below its 200-day average of $15.54.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$7.13
    52-week high$24.27-70.6%
    52-week low$6.53+9.2%
    50-day average$11.84-39.8%
    200-day average$15.54-54.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 83.6%.

    MeasureValue
    1-year beta1.57
    Largest fall, 1 year-71.0%
    Largest fall, 3 years-83.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About AVTX

    What is AVTX's 1-year price change?

    Avalo Therapeutics's price fell 52.8% over the past 12 months. With dividends included, the 12-month total return was -52.8%.

    What is AVTX's 5-year price change?

    Avalo Therapeutics's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 74.5%. These figures leave out dividends.

    What is AVTX's 52-week high and low?

    Avalo Therapeutics's 52-week high is $24.27 and its 52-week low is $6.53. Its latest price of $7.13 on Nov 17, 2026 is 70.6% below the high.

    What is AVTX's beta?

    Avalo Therapeutics's 1-year beta against the S&P 500 is 1.57, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 71.0%.

    Is the AVTX chart free?

    Yes. Advanced Charting for AVTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.